Tracie C.

Tracie C. is a seasoned professional in regulatory affairs, currently serving as a Senior Regulatory Program Director at Genentech since 2012. They have been the early development regulatory lead for neuroscience and immunology products, acting as the primary liaison with the FDA and developing regulatory strategies. Previously, Tracie held senior regulatory positions at Organon and Merck, where they were instrumental in leading NDA submissions and maintaining INDs for various therapeutic areas. Tracie is pursuing a B.S. and Pharm.D. in Pharmacy at Rutgers, The State University of New Jersey-New Brunswick.